IN168119B - - Google Patents

Info

Publication number
IN168119B
IN168119B IN837/CAL/87A IN837CA1987A IN168119B IN 168119 B IN168119 B IN 168119B IN 837CA1987 A IN837CA1987 A IN 837CA1987A IN 168119 B IN168119 B IN 168119B
Authority
IN
India
Application number
IN837/CAL/87A
Other languages
English (en)
Inventor
Dieter Sauerbier
Uwe Peter Dammann
Otto Isaac
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of IN168119B publication Critical patent/IN168119B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Amplifiers (AREA)
  • Indole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of El Displays (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IN837/CAL/87A 1986-10-31 1987-10-26 IN168119B (en))

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3637089 1986-10-31

Publications (1)

Publication Number Publication Date
IN168119B true IN168119B (en)) 1991-02-09

Family

ID=6312873

Family Applications (1)

Application Number Title Priority Date Filing Date
IN837/CAL/87A IN168119B (en)) 1986-10-31 1987-10-26

Country Status (25)

Country Link
EP (1) EP0265812B1 (en))
JP (1) JPS63159319A (en))
KR (1) KR900003491B1 (en))
AT (1) ATE55250T1 (en))
AU (1) AU598602B2 (en))
CA (1) CA1314231C (en))
DD (1) DD262582A5 (en))
DE (1) DE3764235D1 (en))
DK (1) DK169308B1 (en))
EG (1) EG18333A (en))
ES (1) ES2017982B3 (en))
FI (1) FI87140C (en))
GE (1) GEP19971025B (en))
GR (1) GR3000708T3 (en))
HU (1) HU197987B (en))
IL (1) IL84312A (en))
IN (1) IN168119B (en))
LV (1) LV10051B (en))
MX (1) MX8958A (en))
NO (1) NO873860L (en))
PT (1) PT86032B (en))
RU (1) RU1836079C (en))
UA (1) UA11075A (en))
YU (1) YU197387A (en))
ZA (1) ZA878183B (en))

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
WO1995007083A1 (en) * 1993-09-10 1995-03-16 F.H. Faulding & Co. Limited Ifosfamide lyophilisate composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
ES2253877T3 (es) * 1998-03-03 2006-06-01 SHIONOGI & CO., LTD. Composiciones farmaceuticas que contienen el inhibidor de fosfolipasa((3-(2-amino-1,2-dioxoetil)-2-etil-1-(fenilmetil)-1h-indol-4-il)oxi)acetato de sodio.
AU2003276689B2 (en) * 2002-09-05 2009-04-09 Bharat Serums And Vaccines Ltd. Liquid stable composition of oxazaphosphorine with mesna
CN100463678C (zh) * 2002-12-02 2009-02-25 印度血清及疫苗有限公司 用于肠胃外给药的异环磷酰胺组合物及其制备方法
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
SI2071917T1 (sl) * 2006-09-29 2013-03-29 Infa S.A. Pakirni sistem za farmacevtske sestavke in komplet za intravensko aplikacijo
CN105900385B (zh) * 2014-12-04 2019-08-27 华为技术有限公司 在数据通信网中的负载分配

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3732340A (en) * 1966-07-11 1973-05-08 Asta Werke Ag Chem Fab N',o-propylene phosphoric acid ester diamides
DE2750207A1 (de) * 1977-05-09 1978-11-16 Walton J Smith Gefriergetrocknete zusammensetzungen, insbesondere gefriergetrocknete pharmazeutische praeparate und verfahren zu deren herstellung
EP0083439B1 (de) * 1981-12-31 1989-07-26 ASTA Pharma AG 4-Sulfido-oxazaphosphorine und deren Verwendung bei der Krebsbekämpfung und zur Immunsuppression
US4537883A (en) * 1982-11-12 1985-08-27 Mead Johnson & Company Lyophilized cyclophosphamide

Also Published As

Publication number Publication date
DK169308B1 (da) 1994-10-10
YU197387A (en) 1988-12-31
JPS63159319A (ja) 1988-07-02
NO873860D0 (no) 1987-09-15
FI87140B (fi) 1992-08-31
CA1314231C (en) 1993-03-09
EG18333A (en) 1993-12-30
MX8958A (es) 1993-12-01
ATE55250T1 (de) 1990-08-15
IL84312A0 (en) 1988-03-31
FI874727L (fi) 1988-05-01
ES2017982B3 (es) 1991-03-16
LV10051B (en) 1995-06-20
DD262582A5 (de) 1988-12-07
HUT44932A (en) 1988-05-30
PT86032B (pt) 1990-08-31
GR3000708T3 (en) 1991-10-10
UA11075A (uk) 1996-12-25
FI87140C (fi) 1992-12-10
AU598602B2 (en) 1990-06-28
IL84312A (en) 1991-11-21
DK569687A (da) 1988-05-01
JPH0543684B2 (en)) 1993-07-02
ZA878183B (en) 1988-05-02
GEP19971025B (en) 1997-04-06
FI874727A0 (fi) 1987-10-27
HU197987B (en) 1989-07-28
PT86032A (de) 1987-11-01
KR880004814A (ko) 1988-06-27
AU8052987A (en) 1988-05-05
KR900003491B1 (ko) 1990-05-21
LV10051A (lv) 1994-05-10
EP0265812B1 (de) 1990-08-08
DK569687D0 (da) 1987-10-30
RU1836079C (ru) 1993-08-23
NO873860L (no) 1988-05-02
DE3764235D1 (de) 1990-09-13
EP0265812A1 (de) 1988-05-04

Similar Documents

Publication Publication Date Title
AU7131891A (en))
GR3004723T3 (en))
DE3778842D1 (en))
DE3784372D1 (en))
DE3683300D1 (en))
FR2600019B1 (en))
IN168119B (en))
IN170821B (en))
AU7354491A (en))
IN169132B (en))
AU5558386A (en))
AU5130285A (en))
AU5480786A (en))
AU5614386A (en))
AU5614486A (en))
AU5444986A (en))
AU5644686A (en))
AU5442686A (en))
AU5348186A (en))
AU5655786A (en))
AU4596985A (en))
AU5344086A (en))
AU5173485A (en))
AU5130385A (en))
AU5745586A (en))